Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Lotus Books Solid 2008; Still Needs Cash

publication date: Apr 16, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Lotus Pharmaceuticals (路坦制药有限公司) filed its 2008 financial report showing the company’s revenues, which totaled $73.8 million, were up 30% while net income rose 14% to $12.8 million or 27 cents per fully diluted share. The company said it expected to see “steady” growth in 2009. Unfortunately, Lotus ended 2008 with just $1.3 million in cash and working capital of $4.4 million with two big-dollar projects in the works. More details...

Stock Symbol: (OTCBB: LTUS)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...



Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China

>>More events...
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners